| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Robert Mapplethorpe Laboratory, Divisions of Experimental Medicine and Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115; and
Division of Hematology/Oncology, Norris Cancer Center, University of Southern California, Los Angeles, CA 90033
Vascular endothelial growth factor (VEGF) appears to be a critical cytokine modulating the growth and spread of Kaposi’s sarcoma (KS). Furthermore, infection with the KS herpes virus results in up-regulation of VEGF and triggering of VEGF receptor activation. The molecular mechanisms regulating such cytokine-driven proliferation of KS cells are not well characterized. We investigated the role of Src-related tyrosine kinases in VEGF-mediated signaling in model KS 38 tumor cells. VEGF stimulation specifically activated c-Src kinase activity but not that of other related Src kinases such as Lyn, Fyn, or Hck in KS cells. Pyrazolopyrimidine, a selective inhibitor of Src family tyrosine kinases, significantly blocked the VEGF-induced growth of KS cells. Further studies using mutants of c-Src kinase revealed that Src mediates mitogen-activated protein kinase activation induced by VEGF. We also observed that VEGF stimulation resulted in increased tyrosine phosphorylation of the focal adhesion components paxillin and p130cas. Furthermore, VEGF induction enhanced the complex formation between Src kinase and paxillin. Src kinase appears to play an important functional role in VEGF-induced signaling in KS cells and may act to link pathways from the VEGF receptor to mitogen-activated protein kinase and cytoskeletal components, thereby effecting tumor proliferation and migration.
This article has been cited by other articles:
|
|
 |
|
  P. Hingorani, W. Zhang, R. Gorlick, and E. A. Kolb Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo Clin. Cancer Res., May 15, 2009; 15(10): 3416 - 3422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chabot, K. Spring, J.-P. Gratton, M. Elchebly, and I. Royal New Role for the Protein Tyrosine Phosphatase DEP-1 in Akt Activation and Endothelial Cell Survival Mol. Cell. Biol., January 1, 2009; 29(1): 241 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, D. B. Jump, W. J. Esselman, and J. V. Busik Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through Modification of Caveolae/Lipid Rafts by Docosahexaenoic Acid Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 18 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wu, S. Singh, M.-M. Georgescu, and R. B. Birge A role for Mer tyrosine kinase in {alpha}v{beta}5 integrin-mediated phagocytosis of apoptotic cells J. Cell Sci., February 1, 2005; 118(3): 539 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Cho, V. M. Chennathukuzhi, M. A. Handel, J. Eppig, and N. B. Hecht The Relative Levels of Translin-associated Factor X (TRAX) and Testis Brain RNA-binding Protein Determine Their Nucleocytoplasmic Distribution in Male Germ Cells J. Biol. Chem., July 23, 2004; 279(30): 31514 - 31523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Henriksen, M. Karsdal, J.-M. Delaisse, and M. T. Engsig RANKL and Vascular Endothelial Growth Factor (VEGF) Induce Osteoclast Chemotaxis through an ERK1/2-dependent Mechanism J. Biol. Chem., December 5, 2003; 278(49): 48745 - 48753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumoto, J. Jiang, K. Kiguchi, L. Ruffino, S. Carbajal, L. Beltran, D. K. Bol, M. P. Rosenberg, and J. DiGiovanni Targeted Expression of c-Src in Epidermal Basal Cells Leads to Enhanced Skin Tumor Promotion, Malignant Progression, and Metastasis Cancer Res., August 15, 2003; 63(16): 4819 - 4828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Z. Fernandis, R. P. Cherla, and R. K. Ganju Differential Regulation of CXCR4-mediated T-cell Chemotaxis and Mitogen-activated Protein Kinase Activation by the Membrane Tyrosine Phosphatase, CD45 J. Biol. Chem., March 7, 2003; 278(11): 9536 - 9543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Aoki, M. Narazaki, T. Kishimoto, and G. Tosato Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus Blood, November 15, 2001; 98(10): 3042 - 3049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aoki, R. Yarchoan, K. Wyvill, S.-i. Okamoto, R. F. Little, and G. Tosato Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders Blood, April 1, 2001; 97(7): 2173 - 2176. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
